issue

Dec 7, 2018

Volume 14 Number 11

INTERVENTIONS FOR VALVULAR DISEASE AND HEART FAILURE

Independent impact of extent of coronary artery disease and percutaneous revascularisation on 30-day and one-year mortality after TAVI: a meta-analysis of adjusted observational results
D’ascenzo F, Verardi R, Visconti M, Conrotto F, Scacciatella P, Dziewierz A, Stefanini G, Paradis J, Omedè P, Kodali SK, D’Amico M, Rinaldi M, Salizzoni S
10.4244/EIJ-D-18-00098
free
Final results from the REPRISE I study: five-year clinical outcomes with the repositionable and fully retrievable LOTUS valve system
Gooley R, Worthley S, Whitbourn R, Montarello J, Newcomb A, Allocco DJ, Meredith I
10.4244/EIJ-D-18-00664
free

CORONARY INTERVENTIONS

Impact of retrograde approach on long-term clinical outcomes of patients undergoing coronary chronic total occlusion interventions
Tanaka H, Ohya M, Kubo S, Miura K, Otsuru S, Habara S, Tada T, Fuku Y, Goto T, Kadota K
10.4244/EIJ-D-18-00534
free
Prevalence, predictors, and health status implications of periprocedural complications during coronary chronic total occlusion angioplasty
Riley R, Sapontis J, Kirtane AJ, Karmpaliotis D, Kalra S, Jones PG, Lombardi W, Grantham J, McCabe J
10.4244/EIJ-D-17-00976
free
Randomised comparison of a biodegradable polymer ultra-thin sirolimus-eluting stent versus a durable polymer everolimus-eluting stent in patients with de novo native coronary artery lesions: the meriT-V trial
Abizaid A, Kedev S, Kedhi E, Talwar S, Erglis A, Hlinomaz O, Masotti M, Fath-Ordoubadi F, Lemos P, Milewski K, Botelho R, Costa R, Bangalore S
10.4244/EIJ-D-18-00762
free
Intravascular ultrasound findings of the Fantom sirolimus-eluting bioresorbable scaffold at six- and nine-month follow-up: the FANTOM II study
van Zandvoort L, Dudek D, Weber-Albers J, Abizaid A, Christiansen E, Muller DW, Kochman J, Kołtowski Ł, Lassen JF, Wojdyla R, Wykrzykowska JJ, Onuma Y, Daemen J
10.4244/EIJ-D-18-00491
free
Three-year follow-up of the randomised comparison between an everolimus-eluting bioresorbable scaffold and a durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction (TROFI II trial)
Katagiri Y, Onuma Y, Asano T, Iñiguez A, Jensen L, Cequier A, Hofma S, Christiansen E, Suttorp M, Brugaletta S, Räber L, Sabaté M, Windecker S, Serruys PW
10.4244/EIJ-D-18-00839
free
Percutaneous coronary and structural interventions in women: a position statement from the EAPCI Women Committee
Chieffo A, Buchanan G, Mehilli J, Capodanno D, Kunadian V, Petronio AS, Mikhail G, Capranzano P, Gonzalo N, Karam N, Manzo-Silberman S, Schüpke S, Byrne RA, Capretti G, Appelman Y, Morice M, Presbitero P, Radu M, Mauri Ferre J
10.4244/EIJ-D-18-00225
free
Radial haemostasis is facilitated with a potassium ferrate haemostatic patch: the Statseal with TR Band assessment trial (STAT)
Seto AH, Rollefson W, Patel M, Suh WM, Tehrani DM, Nguyen JA, Amador DG, Behnamfar O, Garg V, Cohen M
10.4244/EIJ-D-18-00101
free

Receive our newsletter

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved